We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Willie R. Earley
Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, United States
In presentations
Saturday, June 27, 01:50 PM – 01:50 PM
Efficacy and safety of adjunctive lumateperone 42 mg in major depressive disorder: pooled analysis of demographic and clinical subgroups from Phase 3 randomized placebo-controlled trials
Speaker: Willie R. Earley (Intra-Cellular Therapies, a Johnson & Johnson Company, Senior Vice President, Head of Clinical Development, Bedminster, United States)
